《半日速報》恆指升337點; 恆生科技指數升181點 美團升逾8% 騰訊升逾4%
恆指半日收19,971點,升337點或1.7%。恆生科技指數報4,087點,升181點或4.6%。國指升160點或2.4%,報6,818點。
活躍重磅股表現:
美團(03690.HK) 收164.2元,上升8.2%;
騰訊(00700.HK) 收356.2元,上升4.4%;
阿裏巴巴(09988.HK) 收86.95元,上升1.1%;
港交所(00388.HK) 收329元,上升1%;
友邦(01299.HK) 收73元,下跌0.4%;
平安(02318.HK) 收47.9元,下跌0.2%;
異動恆指及國指成份股:
藥明生物(02269.HK) 收54.3元,上升9.9%;
快手-W(01024.HK) 收63.3元,上升8.2%;
比亞迪(01211.HK) 收231元,上升7.4%;
阿裏健康(00241.HK) 收3.98元,上升7.3%;
信達生物(01801.HK) 收20.85元,上升7.3%;
安踏體育(02020.HK) 收86.95元,上升7.1%;
中芯(00981.HK) 收16.16元,上升6.6%;
舜宇(02382.HK) 收104.1元,上升6.6%;
京東健康(06618.HK) 收42.05元,上升6.5%;
吉利(00175.HK) 收11.88元,上升6.5%;
信義光能(00968.HK) 收11.96元,上升6.4%;
李寧(02331.HK) 收58.5元,上升6.4%;
碧桂園服務(06098.HK) 收27元,上升5.7%;
翰森製藥(03692.HK) 收13.24元,上升5.6%;
網易(09999.HK) 收146.2元,上升5.5%;
華潤啤酒(00291.HK) 收44.35元,上升4.7%;
中生製藥(01177.HK) 收3.9元,上升4.6%;
石藥(01093.HK) 收7.89元,上升4.4%;
中國海外發展(00688.HK) 收22.65元,下跌4.2%;
金沙(01928.HK) 收15.96元,上升3.9%;
申洲(02313.HK) 收97.6元,上升3.7%;
瑞聲(02018.HK) 收17.22元,上升3.4%;
京東物流(02618.HK) 收15.34元,上升3.2%;
京東集團(09618.HK) 收214.6元,上升3.2%;
海底撈(06862.HK) 收13.88元,上升3.1%;
百威亞太(01876.HK) 收19.88元,上升3%;
異動綜合中小型股:
再鼎醫藥SB-新(09688.HK) 收25.7元,上升16.6%;
復星醫藥(02196.HK) 收34.4元,上升14.7%;
科濟藥業-B(02171.HK) 收11.2元,上升10.7%;
雲頂新耀-B(01952.HK) 收17.7元,上升10.1%;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.